Craniosynostosis: Novel insights into pathogenesis and treatment

Current Opinion in Neurology

Volumn 9, Issue 2, 1996, Pages 146-152

  Wilkie, Andrew O M ^a,b   Wall, Steven A ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL MODEL; CRANIOFACIAL SYNOSTOSIS; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; PATHOGENESIS; RABBIT; SHORT SURVEY;

ACROCEPHALOSYNDACTYLIA; CRANIOSYNOSTOSES; HUMANS; MUTATION; RECEPTORS, NERVE GROWTH FACTOR;

EID: 0029885567     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199604000-00016     Document Type: Short Survey

References (84)

1. Hunter AGW, Rudd NL: Craniosynostosis: I. Sagittal synostosis: its genetics and associated clinical findings in 214 patients who lacked involvement of the coronal suture(s). Teratology 1976, 14:185-193.
2. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D: Genetic study of nonsyndromic coronal Craniosynostosis. Am J Med Genet 1995, 55:500-504.
3. Cohen MM Jr: Suturai biology and the correlates of Craniosynostosis. Am J Med Genet 1993, 47:581-616.
4. Cohen MM Jr: Syndromes with Craniosynostosis. In Craniosynostosis: diagnosis, evaluation and management. Edited by Cohen MM Jr. New York: Raven Press; 1986:413-590.
5. Carter CO, Till K, Fraser V, Coffey R: A family study of Craniosynostosis, with probable recognition of a distinct syndrome. J Med Genet 1982, 19:280-285.
6. Graham JM Jr, deSaxe M, Smith DW: Sagittal craniostenosis: fetal head constraint as one possible cause. J Pediatr 1979, 95:747-750.
7. Robin NH, Segel B, Carpenter G, Muenke M: Craniosynostosis, Philadelphia type: a new autosomal dominant syndrome with sagittal craniosynostosis and syndactyly of the fingers and toes. Am J Med Genet 1996, 62:184-191.
8. Reardon W, Winter RM: Saethre-Chotzen syndrome. J Med Genet 1994, 31:393-396.
9. Gorlin RJ, Cohen MM Jr, Levin LS: Syndromes with Craniosynostosis: general aspects and well-known syndromes. In Syndromes of the head and neck, edn 3. Edited by Gorlin RJ, Cohen MM Jr, Levin LS. New York: Oxford University Press; 1990:519-539.
10. Muenke M, Schell U: Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 1995, 11:308-313. Probably the most accessible of a number of reviews to appear this year in the wake of the discovery of FGFR-associated mutations. Contains useful summaries of FGF chromosomal location and function, and the phenotypic features of the various syndromes.
11. Brueton LA, van Herwerden L, Chotai KA, Winter RM: The mapping of a gene for Craniosynostosis: evidence for linkage of the Saethre-Chotzen syndrome to distal chromosome 7p. J Med Genet 1992, 29:681-685
12. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 1994, 8:98-103.
13. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW: Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet 1995, 11:462-464 Just when a pattern was beginning to emerge, with mutations of FGFR 1 and 2 in craniosynostosis and of FGFR3 in short-limbed dwarfism, this paper appeared, reminding us how little we really understand about molecular pathogenesis in the FGF/FGFR signalling pathway. A subset of Crouzon patients with the skin disorder acanthosis nigricans have an amino acid substitution just 11 residues away from that causing achondroplasia. This discovery broadens our perspective on FGFR3-related disorders and may be of particular value for investigating the mechanisms of acanthosis nigricans.
14. •,40]. This is still the only mutation described in FGFR1.
15. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM: Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 1995, 9:173-176. The first paper to demonstrate that Reiffer syndrome could be caused by mutations of FGFR2 as well as FGFR1. Mutation at the same residue, but only occasionally the same substitution, also occurs in Crouzon syndrome.
16. Lajeunie E, Ma HW, Bonaventure J, Munnich A, Le Merrer M, Renier D: FGFR2 mutations in Pfeiffer syndrome. Nature Genet 1995, 9:108.
17. •]).
18. ••]) and the severe limb abnormalities (by contrast with Crouzon syndrome) identify differences in the role of FGFR2 in the developmental patterning of the skull and limb.
19. •]); the large size of this pedigree makes it valuable for further studies of factors influencing phenotypic variability.
20. MacPherson E, Estop A, Paulus-Thomas J: Craniofrontonasal dysplasia in a girl with del (X)(p22.2). Am J Hum Genet 1991 49(suppl):A774.
21. Jabs EW, Müller U, Li X, Ma L, Luo W, Haworth IS, Khsak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R: A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 75:443-450.
22. Hollway GE, Phillips HA, Adès LC, Haan EA, Mulley JC: Localization of craniosynostosis Adelaide type to 4p16. Hum Mol Genet 1995, 4:681-683.
23. Vortkamp A, Gessler M, Grzeschik K-H: GLI3 zinc-finger gene interrupted by translocations in Greig syndrome famlies. Nature 1991, 352:539-540.
24. Tavormina PL, Shiang R, Thompson LM, Zhu Y-Z, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Conn DH, Wasmuth JJ: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 1995, 9:321-328. Thanatophoric dysplasia is a sporadic, lethal bone dysplasia associated with very short limbs; cloverleaf skull is present in about 60% of cases. This elegant paper employed state-of-the art DNA sequencing techniques to identify FGFR3 mutations in both the extracellular and tyrosine kinase domains. The latter finding begs the question as to whether tyrosine kinase mutations of FGFR1 and FGFR2 await discovery.
25. Alderman BW, Bradley CM, Greene C, Fernbach SK, Barón AE: Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology 1994, 50:13-18.
26. Alderman BW, Zamudio S, Barón AE, Joshua SC, Fernbach SK, Greene C, Mangione EJ: Increased risk of craniosynostosis with higher antenatal maternal altitude. Int J Epidemiol 1995, 24:420-426.
27. Bradley CM, Alderman BW, Williams MA, Checkoway H, Fernbach SK, Greene C, Bigelow PL, Reif JS: Parental occupations as risk factors for craniosynostosis in offspring. Epidemiology 1995, 6:306-310.
28. Cohen MM Jr: Lambdoid synostosis is an overdiagnosed condition. Am J Med Genet 1996, 61:98-99.
29. Kirby PJG, Beverley DW, Batchelor AG: Frequency of craniosynostosis in Yorkshire, UK. Lancet 1993, 341:1412-1413.
30. Warman ML, Mulliken JB, Hayward PG, Müller U: Newly recognized autosomal dominant disorder with craniosynostosis. Am J Med Genet 1993, 46:444-449.
31. Müller U, Warman ML, Mulliken JB, Weber JL: Assignment of a gene locus involved in craniosynostosis to chromosome 5qter. Hum Mol Genet 1993, 2:119-122.
32. Semenza GL, Wang GL, Kundu R: DNA binding and transcriptional properties of wild-type and mutant forms of the homeodomain protein MSX2. Biochem Biophys Res Comm 1995, 209:257-262.
33. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MA Jr, Snead ML, Maxson RE Jr.: Premature suture closure and ectopic cranial bone in mice expressing MSX2 transgenes in the developing skull. Proc Natl Acad Sci USA 1995, 92:6137-6141. MSX2 genes (either wild-type or containing the putative mutation in Boston craniosynostosis) were ligated to heterologous promoters (tissue inhibitor of metalloproteinase 1 or cytomegalovirus) and microinjected into mouse zygotes. Craniosynostosis occurred in both wild-type and mutant transgenic lines.
34. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994, 78:335-342.
35. Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet J-M, Maroteaux P, Le Merrer M, Munnich A: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371:252-254.
36. Preston RA, Post JC, Keats BJB, Aston CE, Ferrell RE, Priest J, Nouri N, Losken HW, Morris CA, Hurtt MR et al.: A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nature Genet 1994, 7:149-153.
37. Oldridge M, Wilkie AOM, Slaney SF, Poole MD, Pulleyn LJ, Rutland P, Hockley AD, Wake MJC, Goldin JH, Winter RM et al.: Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet 1995, 4:1077-1082.
38. Park W-J, Meyers GA, Li X, Theda C, Day D, Orlow SJ, Jones MC, Jabs EW: Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 1995, 4:1229-1233.
39. Gorry MC, Preston RA, White GJ, Zhang Y, Singhal VK, Losken HW, Parker MG, Nwokoro NA, Post JC, Ehrlich GD: Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 1995, 4:1387-1390.
40. Meyers GA, Day D, Goldberg R, Daentl D, Przylepa KA, Abrams LJ, Graham JM Jr, Feingold M, Moeschler JB, Rawnsley E et al.: FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 1996, 58:491-498.
41. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide A-L, Maroteaux P, Bonaventure J, Narcy F, Sanak M: Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nature Genet 1995, 10:11-12.
42. Tavormina PL, Rimoin DL, Cohn DH, Zhu Y-Z, Shiang R, Wasmuth JJ: Another mutation that results in the substitution of an unpaired cysteine residue In the extracellular domain of FGFR3 in thanatophoric dysplasia type 1. Hum Mol Genet 1995, 4:2175-2177.
43. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor multigene family. In Advances in Cancer Research. Edited by Van de Woude GF, Klein G. San Diego: Academic Press Inc; 1993:1-41.
44. Mason I: Do adhesion molecules signal via FGF receptors? Curr Biol 1994, 4:1158-1161.
45. Park W-J, Theda C, Maestri NE, Meyers GA, Fryburg JS, Dufresne C, Cohen MM Jr, Jabs EW: Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 1995, 57:321-328.
46. Slaney SF, Oldridge M, Hurst JA, Morris-Kay GM, Hall CM, Poole MD, Wilkie AOM: Differential effects of FGFRZ mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 1996, 58:923-932.
47. Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin R Stenman G, Wilkie AOM: Exclusive paternal origin of new mutations in Apert syndrome. Nature Genet 1996, 13:48-53. A novel application of the amplification refractory mutation system was used to determine the parental origin of mutation in sporadic patients with Apert syndrome; all were paternal in origin. This represents the most skewed parental origin of mutation described for any genetic disease, either because of a high rate of replication errors or positive selection of the mutation during spermatogenesis
48. Steinberger D, Mutliken JB, Müller U: Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet 1995, 96:113-115.
49. Ma HW, Lajeunie E, Le Merrer M, de Parseval N, Serville F, Weissenbach J, Munnich A, Renier D: No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis. Hum Genet 1995, 96:731-735.
50. Steinberger D, Mulliken JB, Müller U: Crouzon syndrome: previously unrecognized deletion, duplication and point mutation within FGFR2 gene. Human Mutat 1996 (In press).
51. •,38,49] leads to abnormal RNA splicing by the creation of a cryptic donor splice site; the same site is activated by an insertion at the normal donor site (40).
52. Del Gatto F, Breathnach R: A Crouzon syndrome synonymous mutation activates a 5' splice site within the IIIc exon of the FGFR2 gene. Genomics 1995, 27:558-559.
53. Cinalli G, Renier D, Sebag G, Saínte-Rose C, Arnaud E, Pierre-Kahn A: Chronic tonsillar hemiation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. J Neurosurg 1995, 83:575-582. A carefully conducted study of plain radiographs, computerised tomography and magnetic resonance images of the skull and brain in a large series of patients. Crouzon syndrome was associated with earlier sagittal suture closure (median 6 months) and a 73% prevalence of chronic tonsillar herniation; corresponding figures for Apert syndrome were 51 months and 2% respectively. Crouzon patients with tonsillar herniation had earlier closure of the lambdoid suture than those who did not.
54. Jackson CE, Weiss L, Reynolds WA, Forman TF, Peterson JA: Craniosynostosis, midfacial hypoplasia, and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr 1976, 88: 963-968.
55. •].
56. Iseki S, Wilkie AOM, Morriss-Kay G M: Expression of the FGFR2 gene during mouse limb and skull development. J Anal 1996, 188:223-224.
57. Wilkie AOM: The molecular basis of genetic dominance. J Med Genet 1994, 31:89-98.
58. •] that Crouzon FGFR2 mutations generate FGF-independent, constitutively activated dimers.
59. Lewanda AF, Green ED, Weissenbach J, Jerald H, Taylor E, Summar ML, Phillips JA III, Cohen M, Feingold M, Mouradian W et al.: Evidence that the Saethre-Chotzen syndrome locus lies between D7S664 and D7S507, by genetic analysis and detection of a microdeletion in a patient. Am J Hum Genet 1994, 55:1195-1201.
60. Wilkie AOM, Yang SP, Summers D, Poole MD, Reardon W, Winter RM: Saethre-Chotzen syndrome associated with balanced translocations involving 7p21.2: three further families. J Med Genet 1995, 32:174-180.
61. Rose CSP, King AAJ, Summers D, Palmer R, Yang S, Wilkie AOM, Reardon W, Malcolm S, Winter RM: Localization of the genetic locus for Saethre-Chotzen syndrome to a 6 cM region of chromosome 7 using four cases with apparently balanced translocations at 7p21.2. Hum Mol Genet 1994, 3:1405-1408.
62. Tsuji K, Narahara K, Yokoyama Y, Grzeschick K-H, Kunz J: The breakpoint on 7p in a patient with t(6;7) and craniosynostosisis is spanned by a YAC clone containing the D75503 locus. Hum Genet 1995, 95:303-307. Several groups are attempting to clone the Saethre-Chotzen gene (genes?) and this is the closest to date - a yeast artificial chromosome clone that spans a translocation breakpoint.
63. Collins FS: Positional cloning: let's not call it reverse anymore. Nature Genet 1992, 1:3-6.
64. Mooney MP, Losken HW, Tschakaloff A, Siegel MI, Losken A, Lalikos JF: Congenital bilateral coronal suture synostosis in a rabbit and craniofacial growth comparisons with experimental models. Cleft Palate-Craniofac J 1993, 30:121-128.
65. Mooney MP, Losken HW, Siegel MI, Lalikos JF, Losken A, Smith TD, Burrows AM: Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis. Part I: Breeding demographics, inheritance pattern, and craniofacial anomalies. Cleft Palate-Cramotac J 1994, 31:1-7.
66. Mooney MP, Aston CE, Siegel MI, Losken HW, Smith TD, Burrows AM, Wenger SL, Caruso K, Siegel B, Ferrell RE: Craniosynostosis with autosomal dominant transmission in New Zealand white rabbits. J Craniofac Genet Dev Biol 1996, 16:52-63. One of a series of papers to characterise the new dominantly inherited craniosynostotic rabbit. Unfortunately, insufficient attention was devoted early on to the breeding programme, so that the penetrance in the heterozygote, and phenotype of the homozygote, are not yet clear.
67. Burrows AM, Mooney MP, Smith TD, Losken HW, Siegel MI: Growth of the cranial vault in rabbits with congenital coronal suture synostosis. Cleft Palate-Craniofac J 1995, 32:235-246.
68. Smith TD, Mooney MP, Burrows AM, Losken HW, Siegel MI: Postnatal changes in the cranial base in rabbits with congenital coronal suture synostosis. J Craniofac Genet Dev Biol 1996 (In press).
69. Carlton M, Evans M: A Crouzon-like craniofacial dysmorphology in the mouse is caused by insertional mutation in the FGF4 region. Genet Res 1995,65:234. This abstract describes the preliminary characterisation of the new mouse mutant Bulgy-eye (Bey), which has a retroviral vector inserted 6kb upstream of Fgf4, between the tandem Fgf3 and Fgf4 genes. It is suggested that FGF4 is most likely the ligand responsible for the Bey phenotype, but evidence for this has not yet appeared in print.
70. McCarthy JG, Glasberg SB, Cutting CB, Epstein FJ, Grayson BH, Ruff G, Thorne CH, Wisoff J, Zide BM: Twenty-year experience with early surgery for Craniosynostosis: I. isolated craniofacial synostosis-results and unsolved problems Plast Reconstr Surg 1995, 96:272-283.
71. Renier D, Sainte-Rose C, Marchac D, Hirsch JF: Intracranial pressure in craniosynostosis. J Neurosurg 1982, 57:370-377.
72. Kapp-Simmonds KA, Figueroa A, Jocher CA, Schafer M: Longitudinal assessment of mental development in infants with nonsyndromic craniosynostosis with and without cranial release and reconstruction. Plast Reconstr Surg 1993, 92:831-841.
73. Arnaud E, Renier D, Marchac D: Prognosis for mental function in scaphocephaly. J Neurosurg 1995, 83:476-479.
74. Gault DT, Renier D, Marchac O, Jones BM: Intracranial pressure and intracranial volume in children with craniosynostosis. Plast Reconstr Surg 1992, 90:377-381.
75. Posnick JC, Armstrong O, Bite U: Metopic and sagittal synostosis: intracranial volume measurements prior to and after cranio-orbital reshaping in childhood. Plast Reconstr Surg 1995, 96:299-309.
76. Kelly MA, Wall SA, Slavin A. Earle JA: Evaluation of cerebral perfusion in craniosynostosis. Presentation: Association of Plastic and Reconstructive Surgeons of Southern Africa Congress, 1992.
77. Sen A, Dougal P, Padhy AK, Bhattacharya A, Kumar R, Bal C, Bajpai M, Bharadwaj M, Mitra DK, Basu AK: Technetium-99m-HMPAO SPECT cerebral blood-flow study in children with craniosynostosis. J Nucl Med 1995, 36:394-398. This paper represents an important study published with normal controls documenting perfusion abnormalities underlying stenosed sutures in craniosynostosis.
78. David LR, Argenta L, Wilson J, Watson N: Cerebral perfusion defects secondary to isolated craniosynostosis. Presentation, VIth International Congress, International Society of Craniofacial Surgery, October 1995.
79. Iqbal JB, Hockley AD, Wake MJC, Goldin JH: Transcranial Doppler sonography in craniosynostosis. Child's Nerv Syst 1994, 10:259-263.
80. Antikainen T, Kallioinen M, Pohjonen T, Törmälä P, Waris T, Serlo W: Polyglycolic acid membrane interpositioning for the prevention of skull deformity following experimental craniosynostosis. Pediatr Neurosurg 1994, 21:77-82.
81. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC: Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dynamics 1993, 198:312-322.
82. Opperman LA, Persing JA, Sheen R, Ogle RC: In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseus obliteration. J Craniofac Surg 1994, 5:327-332.
83. Opperman LA, Passarelli RW. Morgan EP, Reintjes M, Ogle RC: Cranial sutures require tissue interactions with dura mater to resist osseus obliteration in vitro. J Bone Min Res 1995, 10:1978-1987. Calvarial sutures from 20-day-old fetal rats (prior to definitive suture morphogenesis) may be cultured in vitro in a chemically defined serum free medium and continue to follow normal morphological evolution. By five days, bony fusion across the coronal suture occurs in the absence of dura mater; in its presence (even when separated by a polycarbonate filter), patency is maintained.
84. Opperman LA, Passarelli RW, Nolen AA, Lin KY, Gampper TG, Lin KYK, Ogle RC: Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In vitro Cell Devel Biol 1996 (In press).